Exposing the Surrogacy-to-Trafficking Pipeline in India and its Ethical Implications
- BerryBeat Team
- Jul 17
- 4 min read
Surrogacy and egg donation in India have long been framed as medical services offering hope to infertile couples. Yet beneath this veneer lies a troubling reality: a trafficking pipeline that exploits vulnerable women under the guise of legality and consent. In 2025, multiple raids and investigations across Indian states revealed how the fertility industry’s dark underbelly operates openly, dressed in medical language and consent forms that mask coercion and abuse. This post examines the surrogacy trafficking India 2025 crisis, focusing on key cases, the health risks faced by egg donors, and the gaps in regulation that allow exploitation to persist.
The ART Bank Kerala Trafficking Case and Its Wider Implications
In August 2025, the Kerala Health Department raided a facility in Ernakulam known as ART Bank. The raid uncovered multiple women brought from other states, financially desperate, housed on-site as egg donors. These women were recruited under promises of financial support but found themselves trapped in conditions resembling illegal detention. When ART Bank challenged the raid in the Kerala High Court, the state responded with allegations of organised human trafficking.
On September 29, 2025, the Kerala High Court expressed shock and concern over the findings. By December 5, it ordered a Special Investigation Team to probe deeper into the ART Bank Kerala trafficking case. This case exposed how the India fertility industry trafficking pipeline operates openly, using medical jargon and consent forms to obscure coercion.
The ART Bank case is not isolated. It highlights systemic issues where economically vulnerable women, often from tribal or marginalized communities, are recruited into surrogacy and egg donation under false pretenses. The consent forms they sign do not reflect true informed consent but serve as legal cover for exploitation.
Egg Donation Exploitation and Health Risks in India’s Fertility Industry
Egg donation in India carries significant health risks, especially when women undergo repeated extraction cycles without adequate medical supervision. Investigations in Hyderabad and Maharashtra in 2025 revealed alarming patterns of exploitation:
In Hyderabad, raids on Srushti Fertility Centers led to the arrest of 25 people. A former surrogate recruited low-income women into surrogacy and kept them in her home, creating a network that bypassed medical oversight.
Doctors reported treating multiple young women for Ovarian Hyperstimulation Syndrome (OHSS) and internal bleeding, serious complications linked to egg donation.
An unlicensed center in Hyderabad was found recruiting destitute women at Rs 4,000 per egg extraction, requesting repeat donations every three months, far exceeding the legal limit.
These findings underscore the OHSS India egg donor health risks and the broader issue of egg donation exploitation India. The ART Regulation Act, 2021 permits egg donation only once per woman to protect health and prevent exploitation. However, this rule applies only to registered clinics. Unlicensed centers and informal networks continue to operate unchecked, exploiting the enforcement gap.
The ART Regulation Act Enforcement Gap and Its Consequences
The ART Regulation Act, 2021 was designed to regulate assisted reproductive technologies, including surrogacy and egg donation. It sets clear limits, such as allowing egg donation only once per woman, to safeguard health and rights. Yet, enforcement remains weak, especially against unlicensed clinics and informal recruitment networks.
This enforcement gap fuels the India fertility industry trafficking pipeline by allowing middlemen and unregistered facilities to recruit vulnerable women repeatedly, often without proper medical care or informed consent. The pipeline thrives in economic desperation, where women from tribal or marginalized backgrounds are lured by recruiters promising quick money.
A 2025 study published in Frontiers in Sociology documented how India’s surrogacy ban pushed the industry underground and abroad, shifting exploitation to unregulated oocyte donation and countries with weaker oversight. This shift does not end exploitation; it relocates it, often worsening conditions for women involved.
The consent forms signed by these women are often meaningless. They serve as a paper trail to legalize extraction but do not reflect true understanding or voluntary agreement. This disconnect between legal documentation and lived reality is a core ethical concern.
Ethical Implications and the Need for Reform
The surrogacy trafficking India 2025 crisis raises urgent ethical questions:
How can consent be meaningful when women are economically desperate and poorly informed?
What responsibility do medical professionals have in preventing exploitation and protecting donor health?
How can regulation be enforced effectively to close loopholes exploited by unlicensed centers and middlemen?
Advocates for women’s rights and reproductive justice emphasize the need for:
Stronger oversight of fertility clinics and recruitment agencies
Transparent reporting and accountability mechanisms
Comprehensive health monitoring for egg donors and surrogates
Legal reforms that prioritize the dignity and safety of women over commercial interests
Public awareness is also critical. Many women do not understand the risks of egg donation or surrogacy, nor the legal protections they should have. Education campaigns can empower women to make informed choices and resist coercion.
Moving Forward: Protecting Women in India’s Fertility Industry
The ART Bank Kerala trafficking case and related investigations in Hyderabad and Maharashtra reveal a disturbing reality: surrogacy and egg donation in India are vulnerable to trafficking and exploitation due to weak enforcement and economic inequality.
To address this, stakeholders must:
Strengthen enforcement of the ART Regulation Act, 2021, especially against unlicensed centers
Provide medical and legal support to women affected by exploitation
Promote ethical standards in fertility treatments that prioritize health and consent
Support research and data collection to monitor the industry and identify abuses
The surrogacy trafficking India 2025 crisis is a call to action for policymakers, healthcare providers, and civil society. Protecting women’s rights and health in reproductive services requires vigilance, transparency, and a commitment to justice.
By exposing these abuses and demanding reform, India can build a fertility industry that respects the dignity and safety of all women involved.
Disclaimer: This post provides informational content based on publicly available reports and research. It does not constitute legal or medical advice.
